← All organizations
Government of Hong Kong
GovernmentWebsite ↗
Also known as: Hong Kong Association of Youth Department | Hospital Authority | Hospital Authority, Hong Kong | Innovation and Technology Commission, Hong Kong | The Research Fund for the Control of Infectious Diseases of the Food and Health Bureau, the Government of the Hong Kong SAR
Highest phase reached
Phase 4
First clinical trial
Mar 1, 1999Last known activity
Nov 30, 2025
Timeline
1990s
- Jan 1, 1997
Government of Hong Kong— Founded
Drugs by trial phase (64 distinct, 49 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Other trials (36 own, 0 via acquisition)
Indications
Studied for
- Communicable Diseases
- Constipation
- Coronavirus Infections
- Diabetes Mellitus
- Emergencies
- Glomerulonephritis
- Glomerulonephritis, Membranous
- Glomerulosclerosis, Focal Segmental
- Hypertension
- Infections
- Influenza, Human
- Kidney Diseases
- Lung Neoplasms
- Lupus Nephritis
- Muscle Weakness
- Nephritis
- Paresis
- Respiratory Tract Infections
- Rupture
- Severe Acute Respiratory Syndrome
Recent trials (50)
- NCT06926764OfficialN/ANov 30, 2025
- NCT06739720CollaboratorPhase 2/Phase 3Jan 2, 2025
- NCT06473844Lead sponsorN/ADec 1, 2024
- NCT06473844Sponsor investigatorN/ADec 1, 2024
- NCT06719024Lead sponsorPhase 2/Phase 3Nov 29, 2024
- NCT06719024Sponsor investigatorPhase 2/Phase 3Nov 29, 2024
- NCT04799743CollaboratorN/AApr 1, 2021
- NCT04618497Reponsible party - principal investigatorPhase 3Oct 28, 2020
- NCT04618497Overall official - principal investigatorPhase 3Oct 28, 2020
- NCT04618497Lead sponsorPhase 3Oct 28, 2020
- NCT04494399CollaboratorPhase 2Jul 29, 2020
- NCT04276688CollaboratorPhase 2Feb 10, 2020
- NCT04056845Overall official - principal investigatorN/ASep 1, 2019
- NCT04056845Lead sponsorN/ASep 1, 2019
- NCT04056845Reponsible party - principal investigatorN/ASep 1, 2019
Details
- Founded
- Hong Kong, HK Jan 1, 1997
- Last known activity
- Nov 30, 2025